Message from Michel Pettigrew

The purpose of Ferring, the focus the company has had since its founding over 65 years ago, is to improve the health of patients through high quality and effective medicine. I am proud to work for a company that through its work can meaningfully improve the lives of so many people.

I think it is fair to say that we, at Ferring, have always recognised the serious responsibility attached to addressing the healthcare needs of our patients. Ensuring that quality medicines reach our patients is core to our daily business. We embarked on our CSR journey in 2012 acknowledging that our corporate responsibilities go beyond the safe development, manufacture and sale of our products. These responsibilities embrace how we operate as a business, what impact we have on our environment, supporting the communities around us, and, taking into account a broader humanitarian need in the world.

In early 2015 we published our first CSR Review (reviewing the period up to end of 2014). This second review, covers the period 2015 and 2016. I believe that it illustrates our good progress in integrating responsible approaches into our daily business, although I recognise that we still have some way to go.

We have taken several significant steps during the period – notably including CSR strategies and goals in our next five-year business plan. We are quite far forward too, in developing a global responsibility platform in the area of reproductive health where we feel we can work with partners in the public sector to make a real difference to women’s health. Very importantly, Ferring’s Executive Board decided to join the United Nations Global Compact (UNGC), and to publicly state our aims, strategies and progress in corporate social responsibility. UNGC is the world’s largest responsibility network. Ferring is committed to meeting its standards and requirements and believes that the UNGC will in turn help Ferring in its CSR development.

Thank you for taking an interest in our responsibility programme and progress.

 

 

Michel Pettigrew

President of the Executive Board 
and Chief Operating Officer